valproic acid has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
alpha 1-Antitrypsin Deficiency: Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, JR | 1 |
| Williams, TH | 1 |
| Talbot, IC | 1 |
| Tanner, MS | 1 |
1 other study available for valproic acid and alpha 1-Antitrypsin Deficiency
| Article | Year |
|---|---|
Heterozygous alpha 1-antitrypsin deficiency and valproate hepatotoxicity.
Topics: alpha 1-Antitrypsin Deficiency; Heterozygote; Humans; Infant; Infant, Newborn; Liver; Male; Seizures | 1984 |